These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28417312)

  • 1. The need for national registries for rare endocrine tumor syndromes.
    Leeuwaarde RSV; Herder WW; Valk GD
    Endocrine; 2017 Nov; 58(2):205-206. PubMed ID: 28417312
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemiology of endocrine tumours.
    Monson JP
    Endocr Relat Cancer; 2000 Mar; 7(1):29-36. PubMed ID: 10808194
    [No Abstract]   [Full Text] [Related]  

  • 3. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of endocrine organs: results of the RARECARE project.
    van der Zwan JM; Mallone S; van Dijk B; Bielska-Lasota M; Otter R; Foschi R; Baudin E; Links TP;
    Eur J Cancer; 2012 Sep; 48(13):1923-31. PubMed ID: 22361014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of the French National Data Repository in the field of Rare Diseases].
    Salamanca E
    Med Sci (Paris); 2018 May; 34 Hors série n°1():26. PubMed ID: 29911550
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
    de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
    Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre clinical registries. Establishment of multicentre clinical registries as a basis for comparative evaluation of rare diseases.
    Martus P
    Adv Exp Med Biol; 2003; 528():17-24. PubMed ID: 12918654
    [No Abstract]   [Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple endocrine neoplasia type 1: genetic and clinical aspects].
    Calender A; Cadiot G; Mignon M
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B38-48. PubMed ID: 11449144
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple endocrine neoplasia].
    Tóth M; Rácz K; Jakab C; Gláz E
    Orv Hetil; 1993 Oct; 134(40):2187-94. PubMed ID: 8414461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State of play of French data collections in the field of rare diseases].
    Aymé S
    Med Sci (Paris); 2018 May; 34 Hors série n°1():22-25. PubMed ID: 29911549
    [No Abstract]   [Full Text] [Related]  

  • 12. [Workshops A1 to A5].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):33-9. PubMed ID: 24755177
    [No Abstract]   [Full Text] [Related]  

  • 13. [A Multiple endocrine neoplasia type-1 observatory in a French-speaking area. A tool from the Endocrine Tumor study Group (GTE)].
    Goudet P; Bonithon C; Costa A; Cadiot G; Baudin E; Murat A; Delemer B; Tabarin A; Lecomte P; Calender A;
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):154-9. PubMed ID: 17379178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic Causes of Endocrine Diseases Using the Example of Endocrine Tumor Syndromes].
    Unger N; Klocker AL; Führer D
    Dtsch Med Wochenschr; 2017 May; 142(9):665-672. PubMed ID: 28454200
    [No Abstract]   [Full Text] [Related]  

  • 15. Myths and facts...about multiple endocrine neoplasia type 1.
    Quillen TF
    Nursing; 2006 May; 36(5):31. PubMed ID: 16670586
    [No Abstract]   [Full Text] [Related]  

  • 16. Variations in prevalence of endocrine tumors among different colonies of rats? A retrospective study in the Hannover registry data base.
    Morawietz G; Rittinghausen S
    Arch Toxicol Suppl; 1992; 15():205-14. PubMed ID: 1510590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driving interest in consolidating resources for the creation of a global rare disease patient registry.
    Rubinstein YR; Groft SC
    Contemp Clin Trials; 2010 Sep; 31(5):393. PubMed ID: 20603228
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():23-8. PubMed ID: 27137858
    [No Abstract]   [Full Text] [Related]  

  • 19. NIH/NCATS/GRDR® Common Data Elements: A leading force for standardized data collection.
    Rubinstein YR; McInnes P
    Contemp Clin Trials; 2015 May; 42():78-80. PubMed ID: 25797358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer.
    Sernadela P; González-Castro L; Carta C; van der Horst E; Lopes P; Kaliyaperumal R; Thompson M; Thompson R; Queralt-Rosinach N; Lopez E; Wood L; Robertson A; Lamanna C; Gilling M; Orth M; Merino-Martinez R; Posada M; Taruscio D; Lochmüller H; Robinson P; Roos M; Oliveira JL
    Biomed Res Int; 2017; 2017():8327980. PubMed ID: 29214177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.